Purchases and Sales Made in Q3 2023 in Calliditas Therapeutics Ab (CALT)
This table provides information about the institutional ownership of Calliditas Therapeutics Ab (CALT) during Q3 2023. The information is specifically focused on institutions that hold shares of Calliditas Therapeutics AB.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
BUY
|
- |
11.9KNew |
$186K - $242K
|
11.9K
$475K
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
3.81K+ 330.01% |
$59.7K - $77.5K
|
4.96K
$198K
|
|
|
Aug 14, 2024
Q3 2023
|
Federation Des Caisses Desjardins Du Quebec
Levis, A8 |
BUY
|
- |
450+ 22.11% |
$7.06K - $9.17K
|
2.49K
$99.4K
|
|
|
Nov 13, 2023
Q3 2023
|
Qube Research & Technologies LTD
London, X0 |
BUY
|
- |
72New |
$1.13K - $1.47K
|
72
$2.88K
|
|
|
Nov 09, 2023
Q3 2023
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
10+ 7.19% |
$157 - $204
|
149
$5.96K
|
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 09, 2023
Q3 2023
|
Ubs Group Ag
|
SELL
|
- |
-136- 76.84% |
$2.13K - $2.77K
|
41
$1.64K
|
|
|
Nov 14, 2023
Q3 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-182- 49.86% |
$2.85K - $3.71K
|
183
$7.32K
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-328- 12.35% |
$5.14K - $6.68K
|
2.33K
$93.1K
|
|
|
Nov 16, 2023
Q3 2023
|
Ironwood Investment Management LLC
Boston, MA |
SELL
|
- |
-526- 1.93% |
$8.25K - $10.7K
|
26.7K
$1.07M
|
|
|
Nov 01, 2023
Q3 2023
|
Simplex Trading, LLC
|
SELL
|
- |
-603- 52.94% |
$9.46K - $12.3K
|
536
$21.4K
|